AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Apr 17, 2015

30071_dirs_2015-04-17_ee2d4ef4-09d0-4ca1-a5a3-040af2968814.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-04-15

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-15	ResMed Common Stock	M	5975	$15.52	Acquired	128330.941	Direct
2015-04-15	ResMed Common Stock	S	5975	$73.24	Disposed	122355.941	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-15	ResMed Common Stock Options	$15.52	M	5975	Disposed	2015-11-20	ResMed Commmon Stock (5975)	Direct

Footnotes

F1: This transaction was an automatic sale conducted under an approved 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually.

F3: Multiple lots for the same price for this transaction have been combined.